Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pyrinas Real Estate Management is a Hong Kong-based private real estate investment and management company established in 2018. It is described as the real estate arm of Aeneas Group and an affiliate or wholly owned subsidiary within that broader group ecosystem. The company focuses on healthcare and life science real estate infrastructure rather than drug development, including management of laboratory and clinic facilities in Hong Kong. Pyrinas has also been associated with the launch and management of a U.S.-focused healthcare real estate fund aimed at developing co-working laboratory ecosystems for life sciences startups. It is therefore adjacent to the life sciences sector through real estate and infrastructure, but it is not itself a biotech, pharma, or healthcare therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pyrinas Real Estate Management.